These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1477468)
1. Malignant hyperthermia caused by intravenous lidocaine for ventricular arrhythmia. Tatsukawa H; Okuda J; Kondoh M; Inoue M; Terashima S; Katoh S; Ida K Intern Med; 1992 Aug; 31(8):1069-72. PubMed ID: 1477468 [TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effectiveness of lidocaine in patients with ventricular arrhythmias estimated relative to measurements of drug concentration in serum]. Sinkiewicz W; Marzec A; Hoffman A; Jankowski A; Bartuzi Z; Romański B Kardiol Pol; 1989; 32(7-9):366-71. PubMed ID: 2639975 [TBL] [Abstract][Full Text] [Related]
3. [Malignant hyperthermia in a 41-year-old woman]. Popp M; Seeling W Anaesthesist; 1986 Mar; 35(3):203-5. PubMed ID: 3717538 [TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery. Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835 [TBL] [Abstract][Full Text] [Related]
5. Lidocaine a safe agent to use for dysrhythmias during a malignant hyperthermia crisis. Odom J Orthop Nurs; 1991; 10(3):8. PubMed ID: 2052415 [No Abstract] [Full Text] [Related]
6. A case of malignant hyperthermia during epidural analgesia. Klimanek J; Majewski W; Walencik K Anaesth Resusc Intensive Ther; 1976; 4(2):143-5. PubMed ID: 970624 [TBL] [Abstract][Full Text] [Related]
7. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction. Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677 [TBL] [Abstract][Full Text] [Related]
8. Lignocaine therapy after acute myocardial infarction. Chopra MP; Portal RW; Aber CP Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622 [TBL] [Abstract][Full Text] [Related]
10. Lidocaine (Xylocaine) as an anti-arrhythmic agent. Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507 [No Abstract] [Full Text] [Related]
11. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables. Fredrick DS; Boersma RB Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893 [TBL] [Abstract][Full Text] [Related]
13. Pediatric fulminant malignant hyperthermia with severe electroencephalographic abnormality and brain damage: a case report. Minami S; Ikeda A; Yamada K; Kajihama A; Shimizu H; Nagafuchi H J Med Case Rep; 2023 Apr; 17(1):140. PubMed ID: 37061729 [TBL] [Abstract][Full Text] [Related]
14. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program. Pfeifer HJ; Greenblatt DJ; Koch-Weser J Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076 [TBL] [Abstract][Full Text] [Related]
16. Lidocaine in the early phase of acute myocardial infarction: the controversy over prophylactic or selective use. Zehender M; Kasper W; Just H Clin Cardiol; 1990 Aug; 13(8):534-9. PubMed ID: 2204506 [TBL] [Abstract][Full Text] [Related]